SCHEMBL6887169

SCHEMBL6887169

COc1ccc(OCc2nc3ccccc3n(C)c2=O)cc1OC

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 6/20 0.51
TP53 P04637 4/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HTT P42858 3/20 0.50
NPC1 O15118 5/20 0.48
PKM P14618 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
ALDH1A1 P00352 2/20 0.46
POLB P06746 2/20 0.46
MAPT P10636 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
TSHR P16473 1/20 0.44
CYP2C19 P33261 1/20 0.44
KMT2A Q03164 1/20 0.44
CREBBP Q92793 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6893111 0.88 TP53 (0.54) RAB9ATP53SMN1; SMN2HTTNPC1
SCHEMBL6888788 0.85 TP53 (0.58) RAB9ATP53SMN1; SMN2HTTNPC1
SCHEMBL6783862 0.82 NPC1 (0.65) RAB9ATP53SMN1; SMN2HTTNPC1
SCHEMBL6889302 0.81 NPC1 (0.56) RAB9ASMN1; SMN2HTTNPC1PKM
SCHEMBL6785535 0.79 NPC1 (0.53) RAB9ATP53SMN1; SMN2HTTNPC1
SCHEMBL6783727 0.78 TP53 (0.50) RAB9ATP53SMN1; SMN2HTTNPC1
SCHEMBL6888457 0.77 SMN1; SMN2 (0.55) RAB9ATP53SMN1; SMN2HTTNPC1
SCHEMBL6790005 0.77 HDAC6 (0.56) RAB9ASMN1; SMN2HTTNPC1HDAC6
SCHEMBL6892515 0.74 HDAC6 (0.52) RAB9ASMN1; SMN2HTTNPC1PKM
SCHEMBL3975423 0.71 KDM4E (0.69) RAB9ASMN1; SMN2HTTNPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6815442-B2 A PHENOXY-ALKYL-QUINOXALINONE DERIVATIVES FOR INHIBITING DRUG TRANSPORT PROTEINS THAT EFFLUX THERAPEUTIC AGENTS FROM CELLS; SYNERGISTIC THE PENN STATE RESEARCH FOUNDATION 2004-11-09 US claimed